Dr. Rebecca Feldman on Caveolin-1 and its Potential in Breast Cancer Treatment

Video

Rebecca Feldman, PhD, molecular science liaison/research scientist, Caris Life Sciences, discusses caveolin-1, which has the potential to play a major role in the treatment of breast cancer.

Rebecca Feldman, PhD, molecular science liaison/research scientist, Caris Life Sciences, discusses caveolin-1, which has the potential to play a major role in the treatment of breast cancer.

Feldman says that by targeting caveolin-1, medical professionals could potentially restrict the growth of breast cancer in a patient. She adds that by targeting caveolin-1 and restricting breast cancer growth, new treatments that target EGFR and PDGFRA could also become a possibility. This is due to caveolin-1’s role of signaling processes on the molecular level.

Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
Related Content